Endometrial cancer — sometimes referred to as uterine cancer — is the most common cancer of the female reproductive organs. In the case of this disease, malignant (cancerous) cells form in the endometrium. The endometrium is the lining of the uterus, an organ where a fetus grows. It mainly affecting postmenopausal women. With early detection, … Read more
Vaginal bleeding—also known as spotting—between periods is common among women who have not yet reached menopause. Most commonly, it is caused by hormonal imbalances, stress, and vaginal dryness. Vaginal bleeding in post-menopausal women can, in some cases, be an early sign of cancer and should always be investigated further. Spotting is the primary symptom of … Read more
Tests on living “organoids” created from patients’ ovarian cancer cells proved more accurate than DNA sequencing in predicting tumors’ sensitivity or resistance to chemotherapy drugs – and combining the two methods worked even better, say scientists at Dana-Farber Cancer Institute. The investigators report in Cancer Discovery that ovarian cancer organoids – tiny, three-dimensional spheres of cells … Read more
After two relapses, Janet Sheehan went on a clinical trial for her ovarian cancer. Four months later, her newest tumors were completely gone—and today, she’s relishing in a growing list of family milestones.
Depending on your type of cancer, your care team can include many providers, including five or more physicians. They each play a distinct but equally vital role.
Researchers are applying the knowledge they’ve gained in previous clinical trials as they look into how immunotherapy might provide additional treatment options for patients with recurrent cervical cancer.
Whenever Joan Janssen meets fellow ovarian cancer patients, she shares words of wisdom that she’s gained from seven years of living with the disease. “This is a recurring disease; don’t be stunned if it comes back,” she tells them. “You fought it the first time. You can do it even better the next time.” Janssen … Read more
Ovarian cancer often goes undetected before it reaches more invasive stages, but there is one aspect of the disease that frequently remains ignored even after diagnosis: Its impact upon a patient’s sexual health and function. Now, as research and treatment advances are allowing more women to live longer and healthier with ovarian cancer, Dana-Farber is … Read more
Although she had been fully prepped on what to expect, Barbara Losordo was a bit surprised at the ease and speed of her recovery from surgery for endometrial cancer. Discharged from the hospital the same day she had undergone the procedure, she needed no pain medication afterward. Within a week, she was driving. Within a month, … Read more
For women who inherit a breast and ovarian cancer susceptibility gene like mutant BRCA-1 or BRCA-2, the risk of ovarian and tubal cancers begins to rise significantly at age 40 to 45. Women at this age — and younger — are often advised to have their ovaries and tubes removed as a risk-reducing strategy for … Read more
By Linda Dzobiek I have been living with ovarian cancer for 13 years. I was diagnosed at age 53 with Stage 3C ovarian cancer, and after receiving care near my home in Providence, Rhode Island, my doctor referred me to Dana-Farber’s Susan F. Smith Center for Women’s Cancers for a clinical trial. I have been … Read more
Before her vulvar cancer diagnosis, Ronda Cushman led an energetic life as a physical therapy assistant who exercised each morning. Chemotherapy treatment curtailed both passions, but now Cushman may have a new ally in regaining her strength – and caregivers a new way to monitor her health away from the hospital. This past spring, Cushman … Read more
By Ursula Matulonis, MD, Chief, Division of Gynecologic Oncology Immunotherapy, which has revolutionized the treatment of many types of cancer, is undergoing extensive study in patients with ovarian cancer. Although much of this research is in the early stages, it has produced some intriguing findings about the promise of this approach to treatment. Clinical trials … Read more
Cancer surgery is used to prevent, diagnose, stage, and treat cancer. It is the oldest type of cancer therapy and generally works best for solid tumors contained in one area. The goals of surgery range from diagnosing cancer to restoring the body’s appearance or function. Each cancer type has specific cancer operations that may be … Read more
Unlike many gynecologic cancers, there is a vaccination and screening test for cervical cancer, an important distinction in preventing and identifying the disease, according to Ursula Matulonis, MD, medical director of Gynecologic Oncology in Dana-Farber’s Susan F. Smith Center for Women’s Cancers, and Colleen Feltmate, MD, director of minimally invasive surgery in Gynecologic Oncology at … Read more
Ed. note: Niraparib (Zejula) was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2017, as a maintenance therapy for women with ovarian, fallopian tube, or primary peritoneal cancer. This post was originally published on Oct. 21, 2016. For women with relapsed ovarian cancer that responds to platinum-based chemotherapy, a drug that hampers … Read more
By Ursula Matulonis, MD This is an exciting time for those of us engaged in research and patient care for ovarian cancer. As we’ve learned more about this cancer – its early formation, molecular machinery, and the body’s defenses against it – we’ve also come to understand its weaknesses. An array of new therapies that … Read more
What are night sweats? Night sweats are episodes of excessive perspiration that occur at night while one is asleep. Night sweats and chills People who experience this condition typically report waking with damp bedclothes or sheets, having an increased heart rate, and chills. There are many causes of night sweats, most of which are not … Read more
Ovarian cancer is a complex disease. Cell types, stages, and genetics play an important role for patients and their doctors as they decide which direction to take. Fortunately, patients today have many treatment options and new advances on the horizon. Physician-scientists at the Susan F. Smith Center for Women’s Cancers are leading the way in … Read more
For endometrial cancer, as for virtually every form of cancer, advances in genomics are transforming the understanding and treatment of this disease, which arises in the lining of the uterus or womb. As part of the Profile research project at Dana-Farber, Brigham and Women’s Hospital, and Boston Children’s Hospital, investigators have scanned hundreds of endometrial … Read more